SVdP Pharmacy earns national recognition for commitment to improve high blood pressure
The American Heart Association and the American Medical Association announce the 2019 list of physician practices and health systems receiving a Target: BP™ Recognition Award for their commitment to prioritize blood pressure control within the communities they serve
Dallas, TX— St. Vincent de Paul Pharmacy in North Texas is pleased to be recognized by the American Heart Association (AHA) and the American Medical Association (AMA) as a leader in the national effort to get patient blood pressure rates under control and reduce the number of Americans who have heart attacks and strokes each year.
As part of the 2019 Target: BP Recognition Program, AHA and AMA SVdP Pharmacy as one of 1,183 physician practices and health systems recognized nationwide for their commitment to help patients improve blood pressure control.
Launched in 2015, Target: BP™ is a national initiative between the AHA and AMA aimed at addressing the growing burden of high blood pressure in the U.S. The initiative aims to help health care organizations improve blood pressure control rates through use of the AMA’s evidence-based M.A.P. quality improvement program, and recognizes organizations committed to improving blood pressure control. This year’s Recognition Program recognized organizations representing 29.8 million adult patients, with more than 8 million patients diagnosed with hypertension, across 46 states and territories.
“The St. Vincent de Paul Pharmacy is committed to improving the health and quality of life for the uninsured in North Texas. Heart disease is the number one killer in the U.S., and prescription medications that address high blood pressure, high cholesterol and diabetes are the most-often prescribed medications that our location provides to underserved families,” says Kate Rose Marquez, Director of Development of St. Vincent de Paul North Texas.
There are 116 million U.S. adults living with high blood pressure, the nation’s number one risk factor for heart attack and stroke, and less than half have it controlled to target level. Many patients are unaware of the deadly consequences associated with high blood pressure and that it can be managed working in partnership with their physician to create and follow a treatment plan.
“Although we have the tools to treat high blood pressure, many patients face a variety of barriers that make it difficult to successfully manage the condition. That’s why the American Heart Association and American Medical Association created the Target: BP initiative—to bring patients and providers together to successfully get blood pressure under control,” said AMA President Patrice A. Harris, M.D., M.A. “We applaud the physicians who are already working hard to control their patients’ blood pressure, and we will continue to urge more physician practices, health systems and patients to join this effort to prioritize the rising risk of high blood pressure and improve health outcomes for patients across the nation.”
“Collaboration is key to managing high blood pressure,” said AHA President Robert Harrington, MD, FAHA. “When doctors, clinics, patients and organizations like the American Heart Association and American Medical Association are all working towards the same goal, we have the opportunity for great success. We are pleased to be a part of the success of so many practices – and so many patients – in reducing high blood pressure and improving health.”
SVdP Pharmacy, along with all other practices and health systems being recognized, will be featured in upcoming Target: BP materials. This includes appearing on TargetBP.org, and acknowledged at AMA and AHA events throughout the year.
214-520-0650, x120
Media Contacts:
Kate Rose Marquez
Director of Development
St. Vincent de Paul North Texas
English 
Spanish